<bill session="114" type="s" number="2772" updated="2017-06-02T23:40:54Z">
  <state datetime="2016-04-11">REFERRED</state>
  <status>
    <introduced datetime="2016-04-11"/>
  </status>
  <introduced datetime="2016-04-11"/>
  <titles>
    <title type="official" as="introduced">A bill to eliminate the requirement that veterans pay a copayment to the Department of Veterans Affairs to receive opioid antagonists or education on the use of opioid antagonists.</title>
    <title type="display">A bill to eliminate the requirement that veterans pay a copayment to the Department of Veterans Affairs to receive opioid antagonists or education on the use of opioid antagonists.</title>
  </titles>
  <sponsor id="400013"/>
  <cosponsors>
    <cosponsor id="300065" joined="2016-04-28"/>
    <cosponsor id="400272" joined="2016-05-25"/>
    <cosponsor id="400284" joined="2016-04-11"/>
    <cosponsor id="412247" joined="2016-05-09"/>
  </cosponsors>
  <actions>
    <action datetime="2016-04-11">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2016-04-11" state="REFERRED">
      <text>Read twice and referred to the Committee on Veterans' Affairs.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSVA" name="Senate Veterans' Affairs" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="114" type="s" number="2806"/>
    <bill relation="unknown" session="114" type="s" number="2921"/>
  </relatedbills>
  <subjects>
    <term name="Armed forces and national security"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Health promotion and preventive care"/>
    <term name="Home and outpatient care"/>
    <term name="Veterans' medical care"/>
  </subjects>
  <amendments/>
  <summary date="2016-04-11T04:00:00Z" status="Introduced in Senate">This bill exempts from the requirement that veterans pay a Department of Veterans Affairs copayment for:

 any opioid antagonists furnished to a veteran at high risk for overdose of a specific medication or substance in order to reverse the effect of such an overdose, and education on their use.</summary>
  <committee-reports/>
</bill>
